SEC Form 4 · accession 0001683168-17-003308
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masatsune Okajima
Officer — VP and Head of Japanese Office
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 3:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2017 | M | 48,000 | $4.42 | A | 108,941 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $4.42 | Dec 12, 2017 | M | 48,000 | D | — | Jan 6, 2018 | Common Stock | 48,000 | 0 | D |
Explanation of responses
- F1Includes shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
- F2The option vested over a period of 4 years in equal monthly installments from the 1/7/2008 date of grant and is now fully vested.